Edaravone
Showing 26 - 50 of 70
Amyotrophic Lateral Sclerosis, Respiratory Function, Scopolamine Trial in Shanghai (Scopolamine, atropine, edaravone and
Not yet recruiting
- Amyotrophic Lateral Sclerosis
- +2 more
- Scopolamine, atropine, edaravone and dexmedetomidine
- Edaravone
-
Shanghai, Shanghai, ChinaDepartment of neurology, Ruijin Hospital, Shanghai Jiao Tong Uni
Oct 9, 2020
Stroke, Acute, Intracranial Hemorrhages Trial in Peoria (Y-2(Edaravone And Borneol) Sublingual Tablet)
Unknown status
- Stroke, Acute
- Intracranial Hemorrhages
- Y-2(Edaravone And Borneol) Sublingual Tablet
-
Peoria, IllinoisOSF Healthcare System d/b/a Saint Francis Medical
Feb 13, 2020
Healthy Trial in Glendale (Y-2 Sublingual Tablet, Placebo)
Not yet recruiting
- Healthy
- Y-2 Sublingual Tablet
- Placebo
-
Glendale, CaliforniaParexel International Los Angeles Early Phase Clinical Unit
Jul 10, 2023
Severe Hepatic Impairment, Healthy Trial in Prague, Miskolc, Bratislava (MCI-186)
Completed
- Severe Hepatic Impairment
- Healthy
-
Prague, Czechia
- +2 more
Mar 24, 2020
Renal Impairment, Healthy Trial in Tokyo (MCI-186)
Completed
- Renal Impairment
- Healthy
-
Tokyo, JapanInvestigational site
Feb 13, 2020
Ischemic Stroke Trial in ShenYang (intra-arterial cocktail therapy)
Recruiting
- Ischemic Stroke
- intra-arterial cocktail therapy
-
ShenYang, ChinaGeneral Hospital of Northern Theater Command
Nov 19, 2021
Covid19, Amyotrophic Lateral Sclerosis Trial in Charlotte
Recruiting
- Covid19
- Amyotrophic Lateral Sclerosis
-
Charlotte, North CarolinaNeurosciences Institute, Neurology - Charlotte
Jan 24, 2023
Acute Ischemic Stroke Trial in Shanghai (routine therapy of acute ischemia stroke)
Recruiting
- Acute Ischemic Stroke
- routine therapy of acute ischemia stroke
-
Shanghai, Shanghai, ChinaRuijin hospital
Jun 24, 2023
Neuromuscular Diseases Trial in Isfahan (Edaravone, Riluzole)
Unknown status
- Neuromuscular Diseases
- Edaravone
- Riluzole
-
Isfahan, Iran, Islamic Republic ofEMG Department, Alzahra Hospital
Mar 25, 2019
Acute Ischemic Stroke(AISDTS)
Recruiting
- Ischemic Stroke
-
Nanjing, Jiangsu, ChinaNanjing First Hospital, Nanjing Medical University
Jun 5, 2022
Y-2 Sublingual Tablets in the Treatment of Acute Ischemic Stroke
Recruiting
- Stroke
- Y-2 sublingual tablets
-
Beijin, ChinaPeking University Third Hospital
Jun 27, 2021
Amyotrophic Lateral Sclerosis (ALS) Trial in Lebanon (L-Serine)
Recruiting
- Amyotrophic Lateral Sclerosis (ALS)
-
Lebanon, New HampshireDartmouth-Hitchcock Medical Center
Feb 22, 2022
Amyotrophic Lateral Sclerosis (ALS) Trial in Dallas (Antioxidants)
Recruiting
- Amyotrophic Lateral Sclerosis (ALS)
- Antioxidants
-
Dallas, TexasVA North Texas Health Care System
Mar 25, 2022
Amyotrophic Lateral Sclerosis, ALS Trial in Tel Aviv (PrimeC, Placebo)
Recruiting
- Amyotrophic Lateral Sclerosis
- ALS
- PrimeC
- Placebo
-
Loma Linda, California
- +2 more
Nov 23, 2022
Stroke, Acute Trial in Wuhan (SPT-07A injection, )
Not yet recruiting
- Stroke, Acute
- SPT-07A injection
- placebo
-
Wuhan, Hubei, ChinaWuhan Union Hospital
Dec 15, 2021
ALS, Amyotrophic Lateral Sclerosis Trial in Canada (Pimozide 2mg/day (current) or 4 mg/day (study initiation), Placebo Oral
Unknown status
- ALS
- Amyotrophic Lateral Sclerosis
- Pimozide 2mg/day (current) or 4 mg/day (study initiation)
- Placebo Oral Tablet
-
Calgary, Alberta, Canada
- +8 more
May 26, 2020
Amyotrophic Lateral Sclerosis (ALS) Trial in Watari-gun (MCI-186, Placebo of MCI-186)
Completed
- Amyotrophic Lateral Sclerosis (ALS)
- MCI-186
- Placebo of MCI-186
-
Watari-gun, Miyagi-ken, JapanNational Hospital Organization Miyagi National Hospital
Jul 24, 2018
Amyotrophic Lateral Sclerosis Trial in Italy (Fecal microbiota transplantation, Placebo)
Recruiting
- Amyotrophic Lateral Sclerosis
- Fecal microbiota transplantation
- Placebo
-
Chieti, Italy
- +6 more
Feb 28, 2022